267 related articles for article (PubMed ID: 28784162)
1. Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine.
Advani G; Lim YC; Catimel B; Lio DSS; Ng NLY; Chüeh AC; Tran M; Anasir MI; Verkade H; Zhu HJ; Turk BE; Smithgall TE; Ang CS; Griffin M; Cheng HC
Cell Commun Signal; 2017 Aug; 15(1):29. PubMed ID: 28784162
[TBL] [Abstract][Full Text] [Related]
2. C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases.
Chong YP; Chan AS; Chan KC; Williamson NA; Lerner EC; Smithgall TE; Bjorge JD; Fujita DJ; Purcell AW; Scholz G; Mulhern TD; Cheng HC
J Biol Chem; 2006 Nov; 281(44):32988-99. PubMed ID: 16959780
[TBL] [Abstract][Full Text] [Related]
3. A novel non-catalytic mechanism employed by the C-terminal Src-homologous kinase to inhibit Src-family kinase activity.
Chong YP; Mulhern TD; Zhu HJ; Fujita DJ; Bjorge JD; Tantiongco JP; Sotirellis N; Lio DS; Scholz G; Cheng HC
J Biol Chem; 2004 May; 279(20):20752-66. PubMed ID: 14985335
[TBL] [Abstract][Full Text] [Related]
4. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.
Chong YP; Mulhern TD; Cheng HC
Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715
[TBL] [Abstract][Full Text] [Related]
5. Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice.
Nagy Z; Mori J; Ivanova VS; Mazharian A; Senis YA
Blood; 2020 Apr; 135(18):1574-1587. PubMed ID: 32016283
[TBL] [Abstract][Full Text] [Related]
6. Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases.
Chong YP; Ia KK; Mulhern TD; Cheng HC
Biochim Biophys Acta; 2005 Dec; 1754(1-2):210-20. PubMed ID: 16198159
[TBL] [Abstract][Full Text] [Related]
7. Structural elements and allosteric mechanisms governing regulation and catalysis of CSK-family kinases and their inhibition of Src-family kinases.
Ia KK; Mills RD; Hossain MI; Chan KC; Jarasrassamee B; Jorissen RN; Cheng HC
Growth Factors; 2010 Oct; 28(5):329-50. PubMed ID: 20476842
[TBL] [Abstract][Full Text] [Related]
8. Defining the substrate specificity determinants recognized by the active site of C-terminal Src kinase-homologous kinase (CHK) and identification of β-synuclein as a potential CHK physiological substrate.
Ia KK; Jeschke GR; Deng Y; Kamaruddin MA; Williamson NA; Scanlon DB; Culvenor JG; Hossain MI; Purcell AW; Liu S; Zhu HJ; Catimel B; Turk BE; Cheng HC
Biochemistry; 2011 Aug; 50(31):6667-77. PubMed ID: 21699177
[TBL] [Abstract][Full Text] [Related]
9. Development of the procedures for high-yield expression and rapid purification of active recombinant Csk-homologous kinase (CHK): comparison of the catalytic activities of CHK and CSK.
Chan KC; Lio DS; Dobson RC; Jarasrassamee B; Hossain MI; Roslee AK; Ia KK; Perugini MA; Cheng HC
Protein Expr Purif; 2010 Dec; 74(2):139-47. PubMed ID: 20667476
[TBL] [Abstract][Full Text] [Related]
10. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation.
Ayrapetov MK; Nam NH; Ye G; Kumar A; Parang K; Sun G
J Biol Chem; 2005 Jul; 280(27):25780-7. PubMed ID: 15890649
[TBL] [Abstract][Full Text] [Related]
11. CSK-homologous kinase (CHK/MATK) is a potential colorectal cancer tumour suppressor gene epigenetically silenced by promoter methylation.
Chüeh AC; Advani G; Foroutan M; Smith J; Ng N; Nandurkar H; Lio DS; Zhu HJ; Chong YP; Verkade H; Fujita DJ; Bjorge J; Basheer F; Lim JP; Luk I; Dhillon A; Sakthianandeswaren A; Mouradov D; Sieber O; Hollande F; Mariadason JM; Cheng HC
Oncogene; 2021 Apr; 40(17):3015-3029. PubMed ID: 33767439
[TBL] [Abstract][Full Text] [Related]
12. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
[TBL] [Abstract][Full Text] [Related]
13. Decreased CHK protein levels are associated with Src activation in colon cancer cells.
Zhu S; Bjorge JD; Cheng HC; Fujita DJ
Oncogene; 2008 Mar; 27(14):2027-34. PubMed ID: 17934522
[TBL] [Abstract][Full Text] [Related]
14. Csk homologous kinase (CHK), unlike Csk, enhances MAPK activation via Ras-mediated signaling in a Src-independent manner.
Zagozdzon R; Kaminski R; Fu Y; Fu W; Bougeret C; Avraham HK
Cell Signal; 2006 Jun; 18(6):871-81. PubMed ID: 16168623
[TBL] [Abstract][Full Text] [Related]
15. Regulation, targets and functions of CHK.
Zhu S; Sun R; Guo X; Bao Y; Zhang D
Front Cell Dev Biol; 2022; 10():1068952. PubMed ID: 36568988
[TBL] [Abstract][Full Text] [Related]
16. Conserved hydrophobicity in the SH2-kinase linker is required for catalytic activity of Csk and CHK.
Mikkola ET; Bergman M
FEBS Lett; 2003 Jun; 544(1-3):11-4. PubMed ID: 12782282
[TBL] [Abstract][Full Text] [Related]
17. Expression, purification, and biochemical characterization of Chk, a soluble protein tyrosine kinase.
Ayrapetov MK; Lee S; Sun G
Protein Expr Purif; 2003 Jun; 29(2):148-55. PubMed ID: 12767803
[TBL] [Abstract][Full Text] [Related]
18. Csk homologous kinase (CHK) and ErbB-2 interactions are directly coupled with CHK negative growth regulatory function in breast cancer.
Kim S; Zagozdzon R; Meisler A; Baleja JD; Fu Y; Avraham S; Avraham H
J Biol Chem; 2002 Sep; 277(39):36465-70. PubMed ID: 12122014
[TBL] [Abstract][Full Text] [Related]
19. Global phosphoproteomics reveals crosstalk between Bcr-Abl and negative feedback mechanisms controlling Src signaling.
Rubbi L; Titz B; Brown L; Galvan E; Komisopoulou E; Chen SS; Low T; Tahmasian M; Skaggs B; Müschen M; Pellegrini M; Graeber TG
Sci Signal; 2011 Mar; 4(166):ra18. PubMed ID: 21447799
[TBL] [Abstract][Full Text] [Related]
20. Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation.
Zrihan-Licht S; Deng B; Yarden Y; McShan G; Keydar I; Avraham H
J Biol Chem; 1998 Feb; 273(7):4065-72. PubMed ID: 9461599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
